Journal
NEUROLOGICAL RESEARCH
Volume 25, Issue 7, Pages 697-700Publisher
FOREFRONT PUBL GROUP
DOI: 10.1179/016164103101202183
Keywords
astrocyte; HSP70; geldanamycin; oxygen-glucose deprivation; primary culture
Categories
Funding
- NIGMS NIH HHS [GM49831] Funding Source: Medline
- NINDS NIH HHS [NS37520] Funding Source: Medline
Ask authors/readers for more resources
Recent data show that geldanamycin can protect the brain against stroke in vivo, and this may be due to induction of heat shock proteins. Our previous results show that heat shock protein 70 expression by retroviral transfection protects astrocytes from necrotic injury by combined oxygen-glucose deprivation, an in vitro model of ischemia. This study tested the ability of geldanamycin to protect astrocytes from either necrotic or apoptotic injury induced by oxygen-glucose deprivation. Astrocytes were pre-treated with 0.1 mug ml(-1) geldanamycin in the medium 4, 8, or 16 h before as well as during oxygen-glucose deprivation. Increased protein levels of heat shock protein 70 were observed after 8 h pre-treatment with geldanamycin and increased further at 16 h pre-treatment, as detected by immunoblotting. Geldanamycin pre-treatment protected mature astrocytes from necrotic cell death and young astrocytes from apoptotic death. Geldanamycin protection of astrocytes against in vitro ischemia is likely due to upregulation of heat shock protein 70.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available